Use of Generalized Additive Model to Detect the Threshold of δ-Aminolevulinic Acid Dehydratase Activity Reduced by Lead Exposure

Int J Environ Res Public Health. 2020 Aug 7;17(16):5712. doi: 10.3390/ijerph17165712.

Abstract

Background: Lead inhibits the enzymes in heme biosynthesis, mainly reducing δ-aminolevulinic acid dehydratase (ALAD) activity, which could be an available biomarker. The aim of this study was to detect the threshold of δ-aminolevulinic acid dehydratase activity reduced by lead exposure.

Methods: We collected data on 121 lead workers and 117 non-exposed workers when annual health examinations were performed. ALAD activity was determined by the standardized method of the European Community. ALAD G177C (rs1800435) genotyping was conducted using the polymerase chain reaction and restricted fragment length polymorphism (PCR-RFLP) method. In order to find a threshold effect, we used generalized additive models (GAMs) and scatter plots with smoothing curves, in addition to multiple regression methods.

Results: There were 229 ALAD1-1 homozygotes and 9 ALAD1-2 heterozygotes identified, and no ALAD2-2 homozygotes. Lead workers had significantly lower ALAD activity than non-exposed workers (41.6 ± 22.1 vs. 63.3 ± 14.0 U/L, p < 0.001). The results of multiple regressions showed that the blood lead level (BLL) was an important factor inversely associated with ALAD activity. The possible threshold of BLL affecting ALAD activity was around 5 μg/dL.

Conclusions: ALAD activity was inhibited by blood lead at a possible threshold of 5 μg/dL, which suggests that ALAD activity could be used as an indicator for lead exposure regulation.

Keywords: ALAD polymorphism; blood lead; delta-aminolevulinic dehydratase (ALAD); generalized additive model (GAM); hemopoietic enzyme.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Biomarkers / analysis
  • Genotype
  • Humans
  • Lead / blood*
  • Lead / toxicity
  • Male
  • Occupational Exposure / adverse effects*
  • Polymerase Chain Reaction
  • Polymorphism, Restriction Fragment Length
  • Porphobilinogen Synthase / blood*
  • Porphobilinogen Synthase / deficiency*
  • Porphobilinogen Synthase / genetics
  • Porphyrias, Hepatic / chemically induced
  • Porphyrias, Hepatic / genetics*
  • Risk Factors

Substances

  • Biomarkers
  • Lead
  • Porphobilinogen Synthase

Supplementary concepts

  • Porphyria, Acute Hepatic